Publication | Open Access

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial

Primary ImmunodeficiencyEpidemiologyAntiretroviral TherapyHiv/aids CounsellingTreatment And PreventionStart TrialImmediate InitiationHuman RetrovirusImmunologyVaccine TrialAutoimmunityChronic Viral InfectionHivPublic HealthMedicineAids Pathogenesis